FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106040 [Registered on: 12/03/2026] Trial Registered Prospectively
Last Modified On: 11/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [other]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study to assess the effectiveness of Parasiyadi Choorna in treating Pureeshaja Krimi (intestinal worms infestation) 
Scientific Title of Study   A Randomised controlled clinical study to evaluate the efficacy of Parasiyadi Choorna in the management of Pureeshaja Krimi in children 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Waghmode Pravin Maruti 
Designation  PG Scholar 
Affiliation  Alvas Ayurveda Medical College and Hospital 
Address  Department of kaumarbhrithya 3rd floor Alvas Ayurveda Medical College and Hospital, Moodubidri, Dakshin Kannada Karnataka 574227 India

Dakshina Kannada
KARNATAKA
574227
India 
Phone  9960315558  
Fax    
Email  pravinwaghmode00@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sudha 
Designation  Associate Professor 
Affiliation  Alvas Ayurveda Medical College and Hospital 
Address  Department of kaumarbhrithya 3rd floor Alvas Ayurveda Medical College and Hospital, Moodubidri, Dakshin Kannada Karnataka 574227 India

Dakshina Kannada
KARNATAKA
574227
India 
Phone  9353771815  
Fax    
Email  sudharaj22311@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Waghmode Pravin Maruti 
Designation  PG scholar 
Affiliation  Alvas Ayurveda Medical College and Hospital 
Address  Department of kaumarbhrithya 3rd floor Alvas Ayurveda Medical College and Hospital, Moodubidri, Dakshin Kannada Karnataka 574227 India

Dakshina Kannada
KARNATAKA
574227
India 
Phone  9960315558  
Fax    
Email  pravinwaghmode00@gmail.com  
 
Source of Monetary or Material Support  
Alvas Ayurveda Medical College and Hospital, Moodubidri, Dakshin Kannada Karnataka 574227 India 
 
Primary Sponsor  
Name  Dr Waghmode Pravin Maruti 
Address  Alvas Ayurveda Medical College and Hospital, Moodubidri, Dakshin Kannada Karnataka 574227 India 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Waghmode Pravin Maruti  Alvas Ayurveda Medical College and Hospital  Department of kaumarbhrithya 3rd floor Alvas Ayurveda Medical College and Hospital, Moodubidri, Dakshin Kannada Karnataka 574227 India
Dakshina Kannada
KARNATAKA 
9960315558

pravinwaghmode00@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Alvas Ayurveda Medical college  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:B839||Helminthiasis, unspecified. Ayurveda Condition: KRUMIH/SANJATAKRUMI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Parasiyadi choorna, Reference: Bhaishajya Ratnavali 11th chapter shloka no. 15, Route: Oral, Dosage Form: Churna/ Powder, Dose: 2(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -madhu), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Vidangadi choorna, Reference: Bhaishajya Ratnavali 11chapter shloka no. 17, Route: Oral, Dosage Form: Churna/ Powder, Dose: 2(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -madhu), Additional Information: -
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1. Children of age group between 3 to 12 years irrespective of gender, religion and socioeconomic status.

2. Children having Udara Shoola and Gudakandu in association with one or more symptoms of Pureeshaja Krimi

3. Children diagnosed with infestation of Ascaris Lumbricoids, Entrobius vermicularis, Necator americanus, Ancylostoma duodenale (which are soil-transmitted intestinal helminths) by microscopic stool examination.

4. Children complaining worms in passing stool (Gudamukh Paryasti) along with other symptoms of Krimi 
 
ExclusionCriteria 
Details  1. Ascaris infestation with complication such as intestinal obstruction, pulmonary eosinophilia.

2. Subjects who are having other systemic illness (like neurological, cardiovascular, respiratory) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
subject will be assessed to observe the improvement in guda kandu, udarshoola, Bhaktadwesha,vivarnata,  Patient will be assessed on 0th, 8th,15th day, and followup on 29th day. 
 
Secondary Outcome  
Outcome  TimePoints 
To reduce the repeated occurance of krimi  Before treatment, 8th day, 15 th day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The study is randomized, controlled, comparative clinical study with the standard drug vidangadi choorna and Interventional drug Parasiyadi choorna with the dosage of 3-5yrs =2gms into divided doses, 6-9yrs =3.75gms divided doses, 10 - 12yrs = 5.5 divided doses before food. The study is conducting on subjects of Krimi belonging to age of 3 to 12 years who has given written and verbal consents by parents for undergoing clinical study. Study will be conducting in Alvas Ayurveda medical college and Hospital moodubidri. Interventional period of this study is 15 days, assessment will be done before treatment, 8th, 15th day

 
Close